-logo-1200x675.png?v=20220915161652&w=240&h=240&zc=2){kind=logo}
Revolution Medicines (NASDAQ:RVMD) Given “Outperform” Rating at Wedbush
Wedbush reissued their outperform rating on shares of Revolution Medicines (NASDAQ:RVMD – Free Report) in a research note released on Thursday,RTT News reports. They currently have a $67.00 price target on the stock. A number of other equities research analysts have also weighed in on the stock. Needham & Company LLC reduced their target price […]
Wedbush reissued their outperform rating on shares of Revolution Medicines (NASDAQ:RVMD – Free Report) in a research note released on Thursday,RTT News reports. They currently have a $67.00 price target on the stock. A number of other equities research analysts have also weighed in on the stock. Needham & Company LLC reduced their target price […]
